Viewing Study NCT02664961

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:51 AM
Ignite Modification Date: 2026-02-02 @ 11:45 AM
Study NCT ID: NCT02664961
Status: TERMINATED
Last Update Posted: 2019-07-23
First Post: 2016-01-20
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Study of TRC105 and Bevacizumab in Patients With Refractory Gestational Trophoblastic Neoplasia (GTN)
Sponsor: Tracon Pharmaceuticals Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Gestational Trophoblastic Neoplasia View
None Choriocarcinoma View
None Placental Site Trophoblastic Tumor View
None Epithelioid Trophoblastic Tumor View
Keywords:

Keywords

Keyword Brief Keyword Text View
None TRC105 View
None CD105 View
None Endoglin View
None Angiogenesis inhibitor View
None GTN View
None Bevacizumab View
None Avastin View